R

RareCyte, Inc.

66 employees

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immuno-oncology
tissue IF and H&E imaging
IF microscopy
Single cell analysis
rare cell retrieval
Health Diagnostics
clinical trials
Health Care
Rare Cell Analysis
tissue micro-region retrieval
rare cell isolation
Non-Invasive Prenatal Testing Research
NIPT
cell and gene therapy
oncology
spatial biology
Medical Device
Circulating Tumor Cell Research
Biomarkers
Liquid Biopsy

Date founded

2009

Funding rounds raised

Total raised

$30M

from 10 investors over 10 rounds

R

RareCyte, Inc. raised undisclosed on November 3, 2022

Investors: Gastro-Intestinal Research Foundation

R

RareCyte, Inc. raised $24M on September 9, 2021

Investors: HealthQuest Capital, 5AM Ventures, F-Prime Capital Partners and Logos Global Management, LP

R

RareCyte, Inc. raised $22M on December 19, 2019

Investors: 5AM Ventures and HealthQuest Capital

R

RareCyte, Inc. raised $30M on August 29, 2017

Investors: Telegraph Hill Partners and 5AM Ventures

R

RareCyte, Inc. raised undisclosed on August 21, 2012

Investors: Telegraph Hill Partners

FAQ